JSPR
Jasper Therapeutics
$0.69
+$0.01 (+0.87%)Jul 27, 2026
Key metrics
The numbers that frame JSPR today
- Market cap
- $19.43M
- P/E (TTM)
- -0.3
- EV / FCF
- -0.1
- ROIC
- 698.8%
- Div yield
- 0%
- Debt / equity
- 0.2
- 52wk Low
- $0.32
- 52wk High
- $3.25
Growth
Revenue and earnings trend for JSPR
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about JSPR
Is Jasper Therapeutics a good buy?
No. Jasper Therapeutics has poor quality and poor momentum. Both signals point to a weaker setup. Growth looks strong, which supports the long-term business case, but that is not enough to offset the weak setup. We think Jasper Therapeutics is selling at a very high price.
What is the market capitalization of JSPR?
Jasper Therapeutics's market capitalization is $19.43M.
What is the P/E ratio for JSPR stock?
Jasper Therapeutics's current P/E ratio is -0.3.
What is the 52-week high for JSPR stock?
The 52-week high for Jasper Therapeutics is $3.25. The current close of $0.69 is 78.6% below that high.
What is the 52-week low for JSPR stock?
The 52-week low for Jasper Therapeutics is $0.32. The current close of $0.69 is 120.3% above that low.
Does JSPR stock pay dividends?
Jasper Therapeutics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for JSPR?
Jasper Therapeutics's Debt / Equity ratio is 0.22.